TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

BBOT Announces Poster Presentations at the San Antonio Breast Cancer Symposium (SABCS)

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Bridgebio Oncology Therapeutics
BBOT Announces Poster Presentations at the San Antonio Breast Cancer Symposium (SABCS)

BridgeBio Oncology Therapeutics announced two poster presentations for BBO-10203, a novel small molecule targeting RAS and PI3Kα interactions in cancer treatment, at the San Antonio Breast Cancer Symposium in December 2025.

Insights
BBOT   positive

Company is presenting promising preclinical data for a novel cancer therapeutic approach with potential broad applicability across multiple cancer types